Loading company…
Thiakis develops biopharmaceutical medicines for obesity and related metabolic diseases.
Thiakis is a biopharmaceutical company developing medicines for obesity, type-two diabetes, cardiovascular diseases, and other metabolic diseases. Founded in 2004, the company is based in London, UK, and was at the Series A stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in